Mixed Q1 results for Mister Spex as sales of prescription glasses decline slightly
Mister Spex revenue inched up by 2.0 percent year-on-year to €51.1 million for the first quarter of 2024, decelerating strongly from Q4 2024 when it grew by 7.4 percent. The mid-single digit growth in Germany was insufficient to fully offset a sharp drop in international sales (see table below).
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.